Clinical Trials Browser

Phase 2 × golotimod × Head & Neck × Clear all

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00756951 2009-11-23

SCV-07 OM

Phase 2 Completed

59 enrolled

Head & Neck

Head and Neck Neoplasms, Stomatitis